These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 21045724
1. Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. Bilo G, Caldara G, Styczkiewicz K, Revera M, Lombardi C, Giglio A, Zambon A, Corrao G, Faini A, Valentini M, Mancia G, Parati G. J Hypertens; 2011 Feb; 29(2):380-7. PubMed ID: 21045724 [Abstract] [Full Text] [Related]
2. Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects. Valentini M, Revera M, Bilo G, Caldara G, Savia G, Styczkiewicz K, Parati S, Gregorini F, Faini A, Branzi G, Malfatto G, Magrì D, Agostoni P, Parati G. Cardiovasc Ther; 2012 Aug; 30(4):240-8. PubMed ID: 21883997 [Abstract] [Full Text] [Related]
3. Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats. Bertera FM, Del Mauro JS, Lovera V, Chiappetta D, Polizio AH, Taira CA, Höcht C. Hypertens Res; 2013 Apr; 36(4):349-55. PubMed ID: 23364340 [Abstract] [Full Text] [Related]
4. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. Stoschitzky K, Stoschitzky G, Brussee H, Bonelli C, Dobnig H. Cardiology; 2006 Apr; 106(4):199-206. PubMed ID: 16679760 [Abstract] [Full Text] [Related]
6. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial. Erdoğan O, Ertem B, Altun A. Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293 [Abstract] [Full Text] [Related]
7. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function. Lombardo RM, Reina C, Abrignani MG, Rizzo PA, Braschi A, De Castro S. Am J Cardiovasc Drugs; 2006 Jun; 6(4):259-63. PubMed ID: 16913827 [Abstract] [Full Text] [Related]
8. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension. Zepeda RJ, Castillo R, Rodrigo R, Prieto JC, Aramburu I, Brugere S, Galdames K, Noriega V, Miranda HF. Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478 [Abstract] [Full Text] [Related]
9. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial. Contini M, Apostolo A, Cattadori G, Paolillo S, Iorio A, Bertella E, Salvioni E, Alimento M, Farina S, Palermo P, Loguercio M, Mantegazza V, Karsten M, Sciomer S, Magrì D, Fiorentini C, Agostoni P. Int J Cardiol; 2013 Oct 03; 168(3):2134-40. PubMed ID: 23506636 [Abstract] [Full Text] [Related]
10. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial. Weiss RJ, Stapff M, Lin Y. Am J Cardiovasc Drugs; 2013 Apr 03; 13(2):129-40. PubMed ID: 23519546 [Abstract] [Full Text] [Related]
11. Effects of nebivolol on human platelet aggregation. Falciani M, Rinaldi B, D'Agostino B, Mazzeo F, Rossi S, Nobili B, Rossi F, Filippelli A. J Cardiovasc Pharmacol; 2001 Dec 03; 38(6):922-9. PubMed ID: 11707696 [Abstract] [Full Text] [Related]
12. A comparison of the beta1-selectivity of three beta1-selective beta-blockers. Nuttall SL, Routledge HC, Kendall MJ. J Clin Pharm Ther; 2003 Jun 03; 28(3):179-86. PubMed ID: 12795776 [Abstract] [Full Text] [Related]
13. Impact of beta-adrenoceptor antagonists on myofilament calcium sensitivity of rabbit and human myocardium. Zeitz O, Rahman A, Hasenfuss G, Janssen PM. J Cardiovasc Pharmacol; 2000 Jul 03; 36(1):126-31. PubMed ID: 10892670 [Abstract] [Full Text] [Related]
14. Comparative effects of a new cardioselective beta-blocker nebivolol and nifedipine sustained-release on 24-hour ambulatory blood pressure and plasma lipoproteins. Lacourcière Y, Poirier L, Lefebvre J, Provencher P, Arnott W. J Clin Pharmacol; 1992 Jul 03; 32(7):660-6. PubMed ID: 1353507 [Abstract] [Full Text] [Related]
15. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers. Polónia J, Barbosa L, Silva JA, Bertoquini S. Blood Press Monit; 2010 Oct 03; 15(5):235-9. PubMed ID: 20577082 [Abstract] [Full Text] [Related]
17. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure. Eeftinck Schattenkerk DW, van den Bogaard B, Cammenga M, Westerhof BE, Stroes ES, van den Born BJ. J Hypertens; 2013 Dec 03; 31(12):2447-54. PubMed ID: 24126713 [Abstract] [Full Text] [Related]